RnR Market Research Offers “Innovative CA Tumor Marker Tests Technologies andEmerging Markets” Report at US$ 4850 (Single ...
13. J&J Vitros ECi/ECiQ14. J&J Vitros 360015. J&J Vitros 560016. Olympus AU540017. Olympus AU3000i18. Olympus AU270019. Ro...
8. Biosensors9. Competing/Complementing Technologiesa. CTb. MRIc. NMRd. PETe. Photonics SpectroscopyE. Personal TestingIII...
Correlogic SystemsDakoDecodeDiadexusDiagnocureDiasorinEiken ChemicalEnterixEnzo BiochemEpigenomicsExact SciencesFujirebioG...
Upcoming SlideShare
Loading in …5
×

Innovative CA Tumor Marker Tests Technologies and Emerging Industry Markets

280 views

Published on

RnR Market Research add new medical device market research report on "Innovative CA Tumor Marker Tests Technologies and Emerging Markets" on it's database.Presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
280
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Innovative CA Tumor Marker Tests Technologies and Emerging Industry Markets

  1. 1. RnR Market Research Offers “Innovative CA Tumor Marker Tests Technologies andEmerging Markets” Report at US$ 4850 (Single User License). The report got published inNov 2012.Presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe(France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratorypractice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as salesand market shares for major suppliers.The cancer diagnostics market is on the verge of explosion, as theresearchers approach major technological breakthroughs in tumor diagnosis and therapy, discover newspecific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, theworldwide cancer testing market is promising to be an exciting, dynamic and rapidly expandingfield. Anticipated technological breakthroughs will create numerous opportunities for determining geneticpredisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise ingeriatric population will further compound the growing demand for malignancy assays and the rapid marketexpansion worldwide.The report also examines market applications of DNA probes, biochips/microarrays,monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews featuresand operating characteristics of automated analyzers; profiles leading suppliers and recent market entrantsdeveloping innovative technologies and products; and identifies alternative market penetration strategies andentry barriers/risks.Get your copy of this report @ http://www.rnrmarketresearch.com/innovative-ca-tumor-marker-tests-technologies-emerging-markets-market-report.htmlTable Of ContentI. IntroductionII. CA TUMOR MARKERS Worldwide Market and Technology OverviewA. CA Tumor Markers: Clinical Significanceand Laboratory Practices1. CA 15-3/27.292. CA 19-93. CA 125B. Instrumentation Review AndMarket Needs1. Abbott AxSYM2. Abbott Architect c40003. Abbott Architect i2000 Series4. Abbott Architect ci8200 System5. Beckman Coulter UniCel Series6. Beckman Coulter Access7. Binding Site ESP6008. bioMerieux Mini Vidas9. Carolina Chemistries BioLis 24i10. DiaSorin Liaison11. Horiba ABX Pentra 40012. Inverness DS2
  2. 2. 13. J&J Vitros ECi/ECiQ14. J&J Vitros 360015. J&J Vitros 560016. Olympus AU540017. Olympus AU3000i18. Olympus AU270019. Roche Modular Analytics20. Roche Cobas Integra 40021. Roche Cobas Integra 400 Plus22. Roche Elecsys23. Roche Cobas c31124. Siemens ADVIA Centaur25. Siemens Dimension26. Siemens Dimension RxL Max27. Siemens Dimension Vista 50028. Siemens Immulite29. Siemens Stratus30. Tosoh AIA-Series31. Vital Diagnostics ATAC 800032. Vital Diagnostics Envoy 500C. Current and Emerging Technologies1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Radioimmunoassay (RIA)c. Enzyme Immunoassays (EIA)OverviewELISAImmunofiltrationParticle-Membrane Capture ImmunoassayEnzyme Amplificationd. Fluorescent Immunoassayse. LuminescenceChemiluminescenceBioluminescencef. Latex Agglutinationg. ImmunoprecipitationH. Affinity Chromatographue. Liposome Flow-Injection Immunoassay3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute Myeloid Leukemia (AML)c. Acute Lymphoblastic Leukemia (ALL)d. Malignant LymphomasLymphoid Malignanciese. Chronic Lymphocytic Leukemia (CLL)f. Solid Cancersg. Chromosomal Translocation and Oncogenes5. Artificial Intelligence6. Flow Cytometry7. Two Dimensional Gel Electrophoresis (2-DGE)
  3. 3. 8. Biosensors9. Competing/Complementing Technologiesa. CTb. MRIc. NMRd. PETe. Photonics SpectroscopyE. Personal TestingIII. France: Market Size, Growth and Major Suppliers’Sales and Market SharesIV. Germany: Market Size, Growth and Major Suppliers’Sales and Market SharesV. Italy: Test Volume and Diagnostics Sales Forecast by Market SegmentVI. Japan: Market Size, Growth and Major Suppliers’Sales and Market SharesVII. Spain: Market Size, Growth and Major Suppliers’Sales and Market SharesVIII. U.K.: Test Volume and Diagnostics Sales Forecast by Market SegmentIX. U.S.A.: Market Size, Growth and Major Suppliers’Sales and Market SharesX. Design Criteria for Decentralized Testing ProductsXI. Alternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market Segmentation FactorXII. Potential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesXIII. Competitive ProfilesAbbottAdnaGenApplied Gene TechnologiesArcaBeckman Coulter/DanaherBecton DickinsonBiomedical DiagnosticsbioMerieuxBio-RadCepheid
  4. 4. Correlogic SystemsDakoDecodeDiadexusDiagnocureDiasorinEiken ChemicalEnterixEnzo BiochemEpigenomicsExact SciencesFujirebioGen-ProbeGuided TherapeuticsHologicIpsogenKreatechKyowa MedexLife TechnologiesMackay Life SciencesMyriad GeneticsFor more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441Website: http://www.rnrmarketresearch.com/

×